Asia Pacific Tissue Processing Systems Market
Asia Pacific Tissue Processing Systems Market is growing at a CAGR of 5.7% to reach US$ 76.29 million by 2027 from US$ 49.58 million in 2019 by Product, Volume, End user and Country.

Published On: Feb 2021

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Tissue Processing Systems Market

Tissue transfer processors segment by product is estimated to lead the market growth during the forecast period

According to a new market research study of “Asia Pacific Tissue Processing Systems Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product, Volume, End User and Country.” The Asia Pacific tissue processing systems market is expected to reach US$ 76.29 million in 2027 from US$ 49.58 million in 2019. The market is estimated to grow with a CAGR of 5.7% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific tissue processing systems market and the factors driving market along with those that act as hindrances.

The Asia Pacific tissue processing systems market, by product, is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market in 2019, whereas the tissue transfer processors segment is anticipated to register the highest CAGR in the market during the forecast period. Tissue processing is used to prepare the tissue for microscopic analysis by putting the tissue in a tangible medium. Tissue processing helps provide skinny and high-quality slices mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. For instance, according to the Chinese Journal of Cancer Research, an estimated 2,865,174 cancer deaths occurred in 2018, with 1,791,805 deaths occurring in males and 1,073,369 in females. Thus, increasing prevalence of cancer is likely to boost the demand for tissue processors to perform cancer diagnosis. Also, growing network of diagnostic laboratories across globe is likely to favor the growth of the market.

The growth of the Asia Pacific tissue processing systems market is attributed to key driving factors such as rising prevalence of cancer and increasing number of diagnostic laboratories across globe. However, high cost of cancer diagnostics is expected to restrict the market growth during the forecast period.

MiltenyiBiotec, Leica Biosystems Nussloch GmbH (Danaher) and BioGenex are among the leading companies operating in the Asia Pacific tissue processing systems market.

Asia Pacific Tissue Processing Systems, By Country (% Share)

APAC_Tisue Processing Systems Market

The report segments in Asia Pacific Tissue Processing Systems Market as follows:

By Product

  • Tissue transfer processors
  • Fluid transfer processors

By Volume

  • Small volume processors
  • Medium volume processors
  • Large volume processors

By End User

  • Hospitals
  • Pharmaceutical companies
  • Research laboratories
  • Others

By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com